Analysis: New modalities to redistribute cardiovascular x-ray procedures
Frost & Sullivan has released new analysis into the impact of newer modalities such as computer tomography (CT) and magnetic resonance imaging (MRI) on the use of cardiac and vascular x-ray-based diagnostic procedures.
According to the research, the U.S. Cardiac and Vascular x-ray equipment markets had revenue of $775.4 million in 2004 -- which is projected to climb to $1,006.4 million by 2010.
What remains uncertain is how the use of CT and MRI will impact the cardiac and vascular x-ray market given that these older systems could still be used to verify results, or be used as tools for intervention, Frost & Sullivan said.
Manufacturers of cardiac and vascular x-ray are now faced with a number of challenges, given all of the uncertainties. Frost & Sullivan recommend that the industry pay close attention to purchasing trends and the multitude of scenarios that will impact it, to evaluate the accuracy of the various predictions and future market changes.